{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T18:57:08Z","timestamp":1789066628539,"version":"build-2803163510"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Ophthalmol"],"published-print":{"date-parts":[[2015]]},"DOI":"10.4103\/0301-4738.170986","type":"journal-article","created":{"date-parts":[[2015,12,3]],"date-time":"2015-12-03T06:23:05Z","timestamp":1449123785000},"page":"710","source":"Crossref","is-referenced-by-count":29,"title":["Ocular abnormalities in multi-transfused beta-thalassemia patients"],"prefix":"10.4103","volume":"63","author":[{"given":"Samira","family":"Heydarian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hosein","family":"Karami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MohammadMomeni","family":"Shektaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KiumarsNoruzpour","family":"Dailami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AhmadAhmadzadeh","family":"Amiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MajidReza Sheikh","family":"Rezaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AsadAllah Farrokh","family":"Far","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0301-4738.170986-1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/GIM.0b013e3181cd68ed","article-title":"Beta-thalassemia","author":"Cao","year":"2010","journal-title":"Genet Med"},{"key":"key-10.4103\/0301-4738.170986-2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1182\/blood.V55.1.55.55","article-title":"New approaches to the transfusion management of thalassemia","author":"Propper","year":"1980","journal-title":"Blood"},{"key":"key-10.4103\/0301-4738.170986-3","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJM199409013310903","article-title":"Survival in medically treated patients with homozygous beta-thalassemia","author":"Olivieri","year":"1994","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0301-4738.170986-4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/03630260701726533","article-title":"Ethical issues and risk\/benefit assessment of iron chelation therapy: Advances with deferiprone\/deferoxamine combinations and concerns about the safety, efficacy and costs of deferasirox","author":"Kontoghiorghes","year":"2008","journal-title":"Hemoglobin"},{"key":"key-10.4103\/0301-4738.170986-5","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1182\/blood.V91.4.1446","article-title":"HBED: A potential alternative to deferoxamine for iron-chelating therapy","author":"Bergeron","year":"1998","journal-title":"Blood"},{"key":"key-10.4103\/0301-4738.170986-6","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1056\/NEJM199504063321404","article-title":"Iron-chelation therapy with oral deferipronein patients with thalassemia major","author":"Olivieri","year":"1995","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0301-4738.170986-7","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1182\/blood.V79.10.2741.bloodjournal79102741","article-title":"Reduction of tissue iron stores and normalization of serum ferritin during treatment with the oral iron chelator L1 in thalassemia intermedia","author":"Olivieri","year":"1992","journal-title":"Blood"},{"key":"key-10.4103\/0301-4738.170986-8","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1749-6632.1990.tb24321.x","article-title":"Design, properties, and effective use of the oral chelator L1 and other alpha-ketohydroxypyridines in the treatment of transfusional iron overload in thalassemia","author":"Kontoghiorghes","year":"1990","journal-title":"Ann N Y Acad Sci"},{"key":"key-10.4103\/0301-4738.170986-9","first-page":"45","article-title":"Deferosirox for managing iron overload in people with thalassemia","author":"Meerpohl","year":"2010","journal-title":"Cochrane Collab"},{"key":"key-10.4103\/0301-4738.170986-10","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.ajo.2006.04.030","article-title":"Ocular findings among thalassemia patients","author":"Taher","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.170986-11","first-page":"125","article-title":"Multiple transfused thalassemia major: Ocular manifestations in a hospital-based population","author":"Taneja","year":"2010","journal-title":"Indian J Ophthalmol","ISSN":"https:\/\/id.crossref.org\/issn\/0301-4738","issn-type":"print"},{"key":"key-10.4103\/0301-4738.170986-12","unstructured":"Sathwara N, Marwah K, Jethani J, Patel SH, Shah B. Ocular Abnormalities in Patients with Beta-thalassemia on Transfusion and Chelation Therapy. AIOC; 2009. p. 434-5."},{"key":"key-10.4103\/0301-4738.170986-13","first-page":"519","article-title":"Ocular side effects of desferal in patients with b-thalassemia","author":"Shahriari","year":"2006","journal-title":"Bina J Ophthalmol"},{"key":"key-10.4103\/0301-4738.170986-14","first-page":"11","article-title":"Ocular changes in multi transfused children with b thalassemia receiving deferoxamine: A case control study","author":"Dewan","year":"2011","journal-title":"SA J Child Health"},{"key":"key-10.4103\/0301-4738.170986-15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/bjo.67.1.29","article-title":"Angioid streaks in a case of beta thalassaemia major","author":"Gibson","year":"1983","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.170986-16","first-page":"357","article-title":"Ocular changes in beta thalassemia","author":"Gaba","year":"1998","journal-title":"Ann Ophthalmol"},{"key":"key-10.4103\/0301-4738.170986-17","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/0002-9394(89)90864-7","article-title":"Ocular abnormalities in patients with beta thalassemia","author":"Gartaganis","year":"1989","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.170986-18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3341\/kjo.1988.2.2.69","article-title":"The significance of tear film break-up time in the diagnosis of dry eye syndrome","author":"Lee","year":"1988","journal-title":"Korean J Ophthalmol"},{"key":"key-10.4103\/0301-4738.170986-19","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1600-0420.1997.tb00392.x","article-title":"A new generation of algorithms for computerized threshold perimetry, SITA","author":"Bengtsson","year":"1997","journal-title":"Acta Ophthalmol Scand"},{"key":"key-10.4103\/0301-4738.170986-20","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/978-94-009-3325-5_75","article-title":"Reliability parameters in computerized perimetry?","author":"Heijl","year":"1987","journal-title":"Doc Ophthalmol Proc Ser"},{"key":"key-10.4103\/0301-4738.170986-21","unstructured":"Anderson DR, Patella VM. Automated Static Perimetry. 2nd ed. St. Louis: Mosby; 1999."},{"key":"key-10.4103\/0301-4738.170986-22","unstructured":"Humphrey Instruments Inc. Humphrey Field Analyzer II User\u2019s Guide. San Leandro, CA: Humphrey Instruments Inc.; 1994."},{"key":"key-10.4103\/0301-4738.170986-23","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1444-0938.2010.00579.x","article-title":"Ocular refractive and biometric characteristics in patients with thalassaemia major","author":"Nowroozzadeh","year":"2011","journal-title":"Clin Exp Optom"},{"key":"key-10.4103\/0301-4738.170986-24","first-page":"42","article-title":"Assessing refractive errors in beta-thalassemia major patients","author":"Khalaj","year":"2008","journal-title":"J Guilan Univ Med Sci"},{"key":"key-10.4103\/0301-4738.170986-25","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1444-0938.2009.00385.x","article-title":"Posterior subcapsular opacity in two patients with thalassaemia major following deferiprone consumption","author":"Mehdizadeh","year":"2009","journal-title":"Clin Exp Optom"},{"key":"key-10.4103\/0301-4738.170986-26","first-page":"174","article-title":"Iron and age-related macular degeneration","author":"Blasiak","year":"2009","journal-title":"Klin Oczna"},{"key":"key-10.4103\/0301-4738.170986-27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4103\/0301-4738.98714","article-title":"Desferrioxamine-related ocular toxicity: A case report","author":"Simon","year":"2012","journal-title":"Indian J Ophthalmol","ISSN":"https:\/\/id.crossref.org\/issn\/0301-4738","issn-type":"print"},{"key":"key-10.4103\/0301-4738.170986-28","first-page":"928","article-title":"Ocular complication and visual evoked potential in beta-thalassemia patients on desferal therapy","author":"Rahiminejad","year":"2009","journal-title":"Res J Biol Sci"},{"key":"key-10.4103\/0301-4738.170986-29","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.exer.2010.03.003","article-title":"Iron, the retina and the lens: A focused review","author":"Garc\u00eda-Casti\u00f1eiras","year":"2010","journal-title":"Exp Eye Res"},{"key":"key-10.4103\/0301-4738.170986-30","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/IAE.0b013e318074c290","article-title":"Iron toxicity as a potential factor in AMD","author":"Wong","year":"2007","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.170986-31","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1167\/iovs.08-2850","article-title":"Dysfunction of the retinal pigment epithelium with age: Increased iron decreases phagocytosis and lysosomal activity","author":"Chen","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/0301-4738.170986-32","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/00003226-200310000-00002","article-title":"Alterations in conjunctival cytology and tear film dysfunction in patients with beta-thalassemia","author":"Gartaganis","year":"2003","journal-title":"Cornea"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:36:18Z","timestamp":1786649778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0301-4738.170986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015]]}},"alternative-id":["170986"],"URL":"https:\/\/doi.org\/10.4103\/0301-4738.170986","relation":{},"ISSN":["0301-4738"],"issn-type":[{"value":"0301-4738","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}